ERGO (ERGO) Stock Price & Analysis
ERGO (ERGO) rose 0.00% to USD 0 as of July 25, 2026 at 04:57 UTC, according to Nexqual real-time market data.
ERGO last closed at USD 0; the session ranged USD 0–0 on volume of 150 shares. Market capitalization is $6,732, with a 52-week range of USD 0–0.04 (PNK). Source: Nexqual, July 25, 2026 at 04:57 UTC.
Key Statistics (as of July 25, 2026 at 04:57 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.04 |
| Volume | 150 shares |
| Market Cap | $6,732 |
| Exchange | PNK |
Technical Analysis (ERGO)
Nexqual's technical model rates ERGO "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of July 25, 2026 at 04:57 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (ERGO)
Wall Street analysts rate ERGO "None", per Nexqual as of July 25, 2026 at 04:57 UTC.
| Consensus Rating | None |
|---|
Earnings (ERGO)
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Financials & Fundamentals (ERGO)
| Total Revenue | $265,466 |
|---|---|
| Revenue Growth (YoY) | -32.80% |
| Gross Margin | +65.53% |
| Operating Margin | -730.09% |
| Profit Margin | +0.00% |
| Current Ratio | 0.11 |
| Total Cash | $76,050 |
| Total Debt | $1.05M |
| Free Cash Flow | $-290,649 |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Financial Health Score (ERGO)
Nexqual rates ERGO's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 04:57 UTC.
| Growth | Critical — Revenue -33% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $76K cash vs $1M debt |
| Cash Flow | Weak — FCF negative: -$291K, burning cash |
| Efficiency | Mixed — No data |
Ownership (ERGO)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 33.66M |
| Float | 22.64M |
Source: Nexqual, July 25, 2026 at 04:57 UTC.
Leadership (ERGO)
ERGO is led by Timothy A. Timmins (age 68), CEO & President, per Nexqual as of July 25, 2026 at 04:57 UTC.
| CEO & President | Timothy A. Timmins (age 68) |
|---|---|
| Chairman and Chief Science & Technology Officer | Marvin S. Hausman (age 84) |
| Secretary and Director | Elliot A. L. Shelton (age 75) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HMGN | HEMAGEN DIAGNOSTICS INC | USD 0 | ▲ 0% |
| ATRX | Adhera Therapeutics Inc. | USD 0 | ▲ 0% |
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| EMIS | Emmis Acquisition Corp. | USD 10.19 | ▲ 0.1% |
| IPIC | IPIC ENTERTAINMENT INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:57 UTC. This page is informational and not investment advice.